In the Boardroom
Refine Search
Pharmaceutical
Swedish drug developer Karolinska Development has named Bruno Lucidi as permanent chief executive. 15 October 2014
Pharmaceutical
Although life science company boards are recruiting more women, a lack of managing their talent during their career is slowing the progress towards greater diversity, according to life sciences human resources specialist RSA’s biannual survey of non-executive directors. 14 October 2014
Pharmaceutical
Swedish orphan and niche product specialist Pharmalink has appointed Bengt Julander as chairman of the board of directors, replacing Anders Wiklund. 14 October 2014
Pharmaceutical
Swiss drug major Novartis has announced that three members of its executive committee will leave the company. 9 October 2014
Pharmaceutical
European specialty pharmaceutical company Norgine has appointed Christopher Bath as vice president of global finance. 8 October 2014
Pharmaceutical
Japan’s largest drugmaker Takeda Pharmaceutical has appointed John Boslego as senior vice president and head of development for the company’s global vaccine business unit. 8 October 2014
Pharmaceutical
Canadian biopharmaceutical company Aeterna Zentaris has named Philip Theodore as senior vice president, chief administrative officer, general counsel and corporate secretary. 7 October 2014
Pharmaceutical
Satish Jindal has been appointed to lead the discovery of drug candidates from leading academic institutions at Allied-Bristol Life Sciences, a jointly-owned enterprise between Allied Minds and US drug major Bristol-Myers Squibb. 6 October 2014
Pharmaceutical
US-based clinical biopharmaceutical company Mast Therapeutics has named Edwin Parsley, has joined the company as its chief medical officer and senior vice president. 2 October 2014
Pharmaceutical
US pain therapeutic specialists Relmada Therapeutics has appointed Julie Chen as its Director of Finance and Operations. 2 October 2014
Pharmaceutical
USA-based specialty pharmaceutical company Zynerba Pharmaceuticals, focused on innovative transdermal cannabinoid treatments, has named two leading industry veterans to lead the company. 2 October 2014
Pharmaceutical
Privately-held gastrointestinal company Ritter Pharmaceuticals has appointed Michael Step as chief executive. 1 October 2014
Pharmaceutical
Oncology drug development company focused on antibody drug conjugates targeting major cancers, ADC Therapeutics, has expanded its team significantly as the company’s first antibody drug conjugates enter clinical development. 30 September 2014
Pharmaceutical
UK respiratory specialist Verona Pharma has appointed Biresh Roy as chief financial officer and member of the board of directors, taking over from Richard Bungay. 30 September 2014
Pharmaceutical
Israeli pharma company Protalix BioTherapeutics has appointed Moshe Manor as its new president and chief executive, effective from November 2. 29 September 2014
Pharmaceutical
UK pharma giant GlaxoSmithKline this morning confirmed recent rumors, saying that Sir Philip Hampton will join the company’s board as non-executive director from January 1, 2015, and will become deputy chairman with effect from April 1, 2015. 25 September 2014
Pharmaceutical
UK-based Avillion LLP, a co-developer of late-stage pharmaceutical assets, has named Jarrod Longcor as Chief Business Officer. 23 September 2014
Pharmaceutical
Swiss-based iron deficiency specialist Vifor Pharma has appointed Dario Eklund as head of international business operations, and Abdul Mullick as head of global marketing, at its headquarters in Zurich. 19 September 2014
Pharmaceutical
Pharmaceutical companies have widely adopted strategies to outsource elements of their business operations, as part of an ongoing drive to deliver a more flexible model that unlocks cost efficiencies and alleviates some aspects of risk associated with drug development. Recruiting talent is one such element. However, pharma companies should be wary of saving on recruitment at the risk of missing out on the best candidates, particularly when it comes to senior staff. Director of Interims of RSA, Dafydd Wright explains. 19 September 2014
Pharmaceutical
The board of partners of Germany’s Merck KGaA has promoted Stefan Oschmann to the position of deputy chief executive and Vice Chairman of the Executive Board. 18 September 2014
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze